InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Gill Simba. Insider active across 2 companies, notably Foghorn Therapeutics Inc.. In total, 6 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €404. Activity tracked since 12 September 2022. The latest transaction was filed on 8 May 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
GILL SIMBA is a declarant linked to Evelo Biosciences, Inc., where he is President & CEO, and to Foghorn Therapeutics Inc., where he is Director. He has 6 filings in total, and across the 6 sampled filings the period runs from 2022-09-14 to 2023-11-08, with EUR 0 of buys and EUR 404 of sales, the largest reported transaction being an option exercise for Foghorn Therapeutics Inc. on 2022-09-14.